Aims/hypothesis Substantial evidence suggests a link between elevated inflammation and development of insulin resistance. Toll-like receptor 2 (TLR2) recognises a large number of lipid-containing molecules and transduces inflammatory signalling in a variety of cell types, including insulin-responsive cells. Considering the contribution of the fatty acid composition in TLR2-depedent signalling, we hypothesised that the inflammatory signals transduced by TLR2 contribute to insulin resistance.
Introduction
Insulin resistance is the chief abnormality present in metabolic syndrome. Increasing evidence suggests causative links between inflammation and development of insulin resistance [1, 2] . Thus, the inflammatory nuclear factor kappa B (NF-κB) signalling pathway is activated and pro-inflammatory cytokines are produced in the white adipose tissue (WAT) and livers of insulin-resistant animals and humans [3] [4] [5] . Genetic or pharmacological inhibition of NF-κB pathways and cytokine neutralisation reverses insulin resistance [4, 6] . Previous studies demonstrated that inflammation-induced activation of protein kinases, such as IκB kinases (IKKs), c-jun N-terminal kinases (JNKs) and extracellular signal-regulated kinases (ERKs), inhibits tyrosine phosphorylation of IRS1 and suppresses downstream insulin signalling. This results in inefficient glucose uptake and use [7] [8] [9] . Thus, it is critical to identify the target(s) and mechanism(s) that initiate inflammatory responses leading to insulin resistance.
Insulin resistance is frequently associated with obesity [10] and dyslipidaemia [11] . Obesity is thought to be the most important identified factor contributing to insulin resistance [12] . Dyslipidaemia, characterised by abnormal amounts and composition of lipids and/or lipoproteins in blood, represents an additional risk factor for insulin resistance. NEFAs and triacylglycerols are elevated in obese and diabetic individuals and animals. Previous studies demonstrated that exposure to elevated NEFA causes activation of inflammatory signals and production of cytokines in multiple cell types, and these findings have been correlated with impairments of insulin actions [13, 14] . Thus, circulating lipid and associated inflammation appear to be a link between nutrient excess and insulin resistance. Recent studies have suggested that the induction of inflammatory pathways by dietary factors may mediate through the membrane receptors, including toll-like receptors (TLRs) [15] .
TLRs play a central role in the innate immune response by recognising conserved patterns in diverse pathogenic molecules and activating pro-inflammatory signalling pathways [16, 17] . TLR2, a subclass of TLRs, is the main receptor recognising components of bacterial cell wall, lipoproteins and lipopeptides. Ligand-induced dimerisation of TLR2 with either TLR1 or TLR6 triggers recruitment of adaptor proteins, following a cascade of kinase activation, ultimately leading to activation of NF-κB and production of pro-inflammatory cytokines. The binding specificity of TLR2 with lipoprotein ligand is mediated through its dimerisation with either TLR1 or TLR6. The TLR2-TLR1 complex recognises triacylated lipoprotein, whereas the TLR2-TLR6 complex senses diacylated lipoprotein [18] . Thus, the number of acyl chain of lipoproteins is finely differentiated by TLR1-TLR2 and TLR2-TLR6. In addition to the number of acyl chains, other characteristics, such as length and ester bond of acyl chains, are critical for the biological activity of TLR2-dependent signalling [19, 20] . These results suggest that the fatty acid composition plays a central role in ligand recognition and receptor activation for TLR2. Furthermore, other studies demonstrated that TLR2 is involved in NEFA-induced insulin resistance [21] [22] [23] . It is reasonable to postulate that the fatty acid moiety from nutrients could potentially activate TLR2 and transduce the inflammatory signals.
Although the predominant site of TLR2 production is on cells of the innate immune system [17] , TLR2 is found on a number of insulin-responsive cells, including adipose, skeletal muscle and liver cells [24, 25] . However, the roles of TLR2 in initiating and maintaining inflammatoryassociated insulin resistance and energy homeostasis in vivo have not been established. Here, we show that mice with TLR2 deficiency are protected from developing insulin resistance and adiposity. The increased insulin sensitivity is associated with increased insulin-signal transduction, improved glucose metabolism, and reduced inflammatory cytokine expression and related signalling specifically in the liver.
Methods
Mice Mice deficient in TLR2 (Tlr2 −/− ) were kindly provided by S. Akira [26] and maintained on a C57BL/6 genetic background. Studies were carried out using both male and female Tlr2 −/− mice and age-matched wild-type (WT) C57BL/6 mice, obtained from National Cheng Kung University Laboratory Animal Center. Leptin-deficient (ob/ ob) mice were obtained from the Jackson Laboratory (Bar Harbor, ME, USA Protein analysis For the insulin signalling, 62.5 mU/kg insulin was administered through the portal vein, and muscle tissues were collected 5 min after injection as described by Hirosumi et al. [27] . Liver and WAT tissue samples were collected 2 min after injection with 200 and 500 mU/kg insulin through the portal vein, respectively. Further methods can be found in the ESM.
Results
Upregulation of TLR2 and inflammatory cytokines in WAT and liver of obese mice To examine the association of inflammation with obesity and insulin resistance, we determined the gene expression of inflammatory mediators in the major insulin-responsive tissues of ob/ob mice. We found that mRNA expression of Tnf was significantly elevated in WAT and liver, but not in muscle, of ob/ob mice, compared with those of WT controls (Fig. 1a) . Expression of Il1b and Il6 mRNA was increased in WAT, but not in liver and muscle, of ob/ob mice. The upregulation of inflammatory genes was accompanied by significantly increased expression of TLR2 and moderate induction of TLR4 expression as shown in levels of both mRNA and protein (Fig. 1b,c) . Consistent with this, the upregulation of TLR2 was evident in WAT and liver, but not in muscle. These results imply that obesity and nutrient excess elicit upregulation in expression of inflammatory cytokines and TLR2 predominantly in WAT and liver. This prompted us to test directly whether TLR2 and its induced inflammation are involved in metabolic disturbances.
Increased insulin sensitivity in Tlr2 −/− mice To investigate the role of TLR2 in glucose homeostasis, we examined the plasma levels of glucose and insulin in Tlr2 −/− and WT mice. Plasma glucose and insulin levels after fasting were both significantly lower in Tlr2 −/− mice than in those of RC-fed WT mice (Fig. 2a,b) . Consistent with these findings, Tlr2 −/− mice fed an HF diet had significantly lower glucose and insulin levels relative to their WT controls. To assess the effect of TLR2 deficiency on the whole-body glucose utilisation, we performed an OGTT. Tlr2 −/− mice cleared glucose faster than WT mice, regardless of diet, indicating improved glucose tolerance in Tlr2 −/− mice ( Fig. 2c,d ). This improved glucose tolerance was accompanied by significantly decreased plasma insulin levels during OGTT of Tlr2 −/− mice, regardless of diet (Fig. 2e,f) . Thus, the insulin-resistance index calculated from the OGTT was significantly lower in Tlr2 −/− mice relative to their WT controls with either diet (Fig. 2g) . Consistent with this, insulin tolerance tests (ITT) showed that glucose-lowering effects of insulin were improved in Tlr2 −/− mice regardless of diet (Fig. 2h,i) .
These results demonstrated that the absence of TLR2 increases glucose tolerance and insulin sensitivity regardless of feeding mice RC or an HF diet.
Decreased body weight and fat mass in Tlr2 −/− mice We next asked whether loss of TLR2 alters energy homeostasis in mice. The growth curve of Tlr2 −/− mice was the same as that of WT mice when mice were fed RC, but significantly differed in mice fed the HF diet (Fig. 3a,b) . Body composition analysis by echoMRI identified significantly mice was about 70% that of WT mice. The weights of major organ, including kidney, liver, spleen and heart, were indistinguishable between genotypes. Gastrocnemius skeletal muscle weight of Tlr2 −/− mice was significantly increased. These data indicate that the absence of TLR2 causes reductions in fat deposition and content. While HF feeding increased body weight of WT mice, the increases in body weight of Tlr2 −/− mice were significantly diminished ( Fig. 3b) . Consistent with this, the individual WAT and BAT masses were significantly less in Tlr2 −/− mice fed an HF diet than in WT mice (Fig. 3e) . Microscopically, adipocytes in gonadal WAT of RC-fed aged Tlr2
−/− mice were smaller than WT cells (mean area 821 μm 2 in Tlr2 −/− vs 1503 μm 2 in WT) (Fig. 3f,g ). The numbers of adipocytes were similar in the Tlr2 −/− and WT mice (1.89×10 7 in TLR2 −/− vs 1.73×10 7 in WT). HF feeding led to fat deposition in both Tlr2 −/− and WT mice and the difference in adipocyte size between genotypes was preserved (mean area 2242 μm 2 in Tlr2 −/− vs 3276 μm 2 in WT) (Fig. 3h,i) . The decrease in adipocyte size of Tlr2 −/− mice under HF feeding was associated with a decrease in the number of adipocytes (1.21×10 7 in Tlr2 −/− vs 2.62× 10 7 in WT). Thus, the deficiency of TLR2 brought a shift in the distribution of adipocyte sizes towards smaller adipocytes in WAT (Fig. 3g,i) . The reduction in fat mass of Tlr2 −/− mice appears to result primarily from the reduction in adipocyte size with a modest decrease in adipocyte number. In vitro differentiation of embryonic fibroblasts showed that adipogenic ability judged by the formation of cells staining positive with Oil red O after hormone stimulation was preserved in Tlr2 −/− mice ( Fig. 3j) , ruling out the possibility of defective adipogenic programming with TLR2 deficiency. The critical variables contributing to body weight maintenance include energy intake and expenditure. Metabolic analysis showed that Tlr2 −/− mice had similar daily food intake to WT mice (Fig. 4a) , suggesting that Tlr2
mice have normal energy absorption. Body temperature was modestly increased in male and significantly increased in female Tlr2 −/− mice, regardless of diet (Fig. 4b ). Basal energy expenditure, as measured by oxygen consumption ( I V O 2 ), during the dark phase was dramatically increased in Tlr2 −/− mice (Fig. 4c,d ). As the increases in I V O 2 and I V CO 2 were coordinated, the respiratory exchange ratio was unchanged (Fig. 4e,f) . Consistent with this, vertical rearing of both young and aged Tlr2 −/− mice during the dark phase was markedly increased (Fig. 4g) . Ambulatory locomotor −/− mice during both the dark and light phases was significantly increased (Fig. 4h) . Thus, energy dissipation appeared increased in Tlr2 −/− mice.
Lipid profile and inflammatory mediators in Tlr2
−/− mice WAT actively secretes signalling molecules, including NEFA, adipokines and inflammatory molecules, into the circulation and communicates with other organs to regulate insulin sensitivity [28] . Fasting plasma triacylglycerol and NEFA levels were not distinguishable between genotypes in mice fed RC, and were significantly lower in Tlr2 −/− mice than in WT mice fed an HF diet (Fig. 5a,b) . Plasma cholesterol levels were not different between genotypes, regardless of diet (Fig. 5c ). Circulating leptin and resistin levels were not distinguishable between genotypes in mice fed RC, but were reduced in Tlr2 −/− mice fed an HF diet (Fig. 5d,e) . Adiponectin levels in circulation were comparable between Tlr2 −/− and WT mice, regardless of diet (Fig. 5f ). While circulating inflammatory molecules, including IL-6, monocyte chemotactic protein-1 (MCP-1) and TNF-α, were higher in mice fed an HF diet than in those fed RC, no difference was detectable between genotypes, regardless of diet ( Fig. 5g-i) . Although the decreased levels of plasma triacylglycerol, NEFA and resistin may account for increased insulin sensitivity in Tlr2 −/− mice upon HF feeding, the increased insulin sensitivity was, however, observed in Tlr2 −/− mice fed RC despite any significant change in plasma triacylglycerol, NEFA and resistin. These 
Attenuated local inflammatory cytokine expression and signalling in Tlr2
−/− mice Although the deficiency of TLR2 did not elicit apparent differences in the systemic levels of inflammatory molecules, insulin sensitivity can be affected through the change in local insulin-responsive tissues. We next examined whether the absence of TLR2 would attenuate local inflammation. Tlr2 −/− RC-fed mice exhibited, in liver, a significant reduction in expression of Il6 and a tendency towards decreased Il1b expression, but no change in expression of Tnf and macrophage marker Emr1 (Fig. 6a) .
No difference in expression of these cytokines was identified in WAT and muscle of Tlr2 −/− mice. Interestingly, dramatic reductions in expression of Il1b, Il6 and Emr1 as well as a tendency towards a decrease in expression of Tnf were observed in WAT and liver of Tlr2 −/− mice fed the HF diet (Fig. 6b) . Expression of these genes, except Tnf, remained unaltered in muscle of Tlr2 −/− HF-fed mice (Fig. 6b) .
Because TLR2 has been demonstrated to transduce signal to activate protein kinases, including IKK, JNK and ERK [7] [8] [9] , we examined their phosphorylation in the insulinresponsive tissues. No difference in phosphorylation of IKKα/β and JNK between WT and Tlr2 −/− mice was detectable in WAT, liver and muscle, regardless of diet (Fig. 6c,d ). While phosphorylation of ERK1/2 was similar in WAT and muscle in the WT and Tlr2 −/− mice fed RC, its phosphorylation was markedly decreased in the liver of Tlr2 −/− mice (Fig. 6c) . The decrease in hepatic ERK1/2 phosphorylation was not accompanied by the change of ERK1/2 protein content in the liver. Furthermore, the liverspecific decrease in ERK1/2 phosphorylation was also observed in Tlr2 −/− mice fed the HF diet (Fig. 6d) . Thus, the absence of TLR2 attenuates basal inflammatory cytokine expression and signalling specifically in the liver. Inflammation-induced activation of IKK, JNK and ERK has been shown to phosphorylate IRS1 at its serine residue (s), which further interrupts tyrosine phosphorylation on IRS1 and suppresses insulin signalling [7] [8] [9] . To further evaluate whether the attenuated inflammatory cytokine expression and signalling in the liver of Tlr2 −/− mice correlates with serine phosphorylation of IRS1, we detected the phosphorylation at Ser307 and Ser612 of IRS1. No difference in phosphorylation at Ser307 and Ser612 of IRS1 between WT and Tlr2 −/− livers was detected, regardless of diet (Fig. 6e,f) . These results suggest that TLR2 deficiency did not affect phosphorylation at Ser307 or Ser612 of IRS1 in the liver.
Improved insulin signalling specifically in the liver of Tlr2 −/− mice To determine which insulin-responsive tissue(s) exhibited improved insulin signalling in Tlr2 −/− mice, we examined the insulin action in mice fed RC. Insulinstimulated phosphorylation at Ser473 of protein kinase B (Akt) was increased in liver, but not in WAT and muscle of 
Tlr2
−/− mice, compared with those of WT mice (Fig. 7a ).
This was accompanied by increased tyrosine phosphorylation of IRS1 and association of IRS1: phosphoinositide 3-kinase (PI3K) complex in the livers of Tlr2 −/− mice after insulin stimulation. However, the increases in IRS1 tyrosine phosphorylation and IRS1:PI3K association were not found in WAT and muscle of Tlr2 −/− mice. Consistently, the liverspecific increases in insulin-stimulated Akt phosphorylation, IRS1 tyrosine phosphorylation and IRS1:PI3K association (data not shown) were also observed in Tlr2 −/− mice fed HF diet (Fig. 7b) . Thus, liver appears to be the major tissue with increased insulin signalling in Tlr2 −/− mice.
Improved glucose metabolism in the liver of Tlr2
−/− mice To determine the functional correlates of increased insulin signalling in the livers of Tlr2 −/− mice, we determined aspects of hepatic glucose metabolism. Pyruvate tolerance tests showed that glucose levels were significantly lower in Tlr2 −/− mice in response to the administration of pyruvate, a major gluconeogenesis substrate (Fig. 8a) . We next assessed the effect of TLR2 deficiency in primary hepatocytes isolated from Tlr2 −/− and WT mice. TLR2 deficiency significantly reduced pyruvateinduced glucose release into the medium by primary hepatocytes (Fig. 8b) . To examine the functional effects of TLR2 deficiency on hepatocyte insulin responsiveness, the ability of insulin to inhibit hepatocyte glucose production was determined. Glucose production by WT hepatocytes was reduced by ∼20% within this time period in response to insulin (Fig. 8c) . The inhibition of glucose secretion by insulin in Tlr2 −/− hepatocytes was significantly increased by 50% in comparison with WT hepatocytes. Thus, increased insulin signalling secondary to TLR2 deficiency resulted in an enhancement of insulin to suppress hepatocyte glucose secretion. Together, these results indicate Tlr2 −/− mice have reduced hepatic glucose production and increased response to insulin.
To determine the insulin sensitivity in the skeletal muscle, we performed the in vitro glucose uptake assay. Basal glucose uptake in muscle in vitro was similar between Tlr2
−/− and WT mice (Fig. 8d) . Insulinstimulated glucose uptake in muscle of Tlr2 −/− mice was 1.6 times those of WT, although the difference did not reach the statistical significance. Consistent with this, triacylglycerol content in liver, which is associated with hepatic insulin resistance, was significantly reduced in Tlr2 −/− mice, while muscle triacylglycerol content was not altered in Tlr2 −/− mice (Fig. 8e) .
Discussion
Substantial evidence indicates inflammation as a key mechanism linking metabolic disturbance to nutrient excess. To establish this link, we hypothesised that TLR2 transduces the inflammatory signals and further contributes to insulin resistance. Our findings recapitulated the observation that obesity is associated with elevated expression of inflammatory cytokines in WAT and liver. Moreover, mice lacking TLR2 exhibited enhanced insulin sensitivity, which is accompanied by increased transduction of insulin signal, improved glucose metabolism, and attenuated inflammatory cytokine expression and related signalling specifically in the liver. Thus, our work has identified TLR2 as a key mediator of hepatic inflammation-related signalling and insulin resistance. Body weight represents the homeostasis between energy intake and expenditure. The deficiency of TLR2 caused a reduction in body weight and fat mass without alteration in food intake. Increased energy expenditure and locomotor activity, as well as body temperature, point to increased energy dissipation in Tlr2 −/− mice. It is known that increased physical activity can influence the insulin sensitivity of skeletal muscle, which is consistent with our findings of a modest increase of insulin- stimulated glucose uptake in Tlr2 −/− muscle. However, the differences in body weight and fat mass were not noticeable unless mice were aged up to 11 months or stimulated with a high-energy diet. The reductions in WAT mass and adipocyte size of Tlr2 −/− mice could result from the defect of pre-adipocytes differentiating into adipocytes and/or maturation of adipocytes. To address the bona fide role of TLR2 in adipocyte differentiation and maturation, we subjected embryonic fibroblasts to adipogenesis in vitro. TLR2 deficiency did not influence the abilities of adipocyte differentiation and triacylglycerol accumulation, suggesting that these properties are not affected by TLR2 deficiency. Although the mechanism involved in increased energy expenditure in Tlr2 −/− mice is not clear, the reduced deposition of excess energy in the body potentially contributes to better metabolic profiles and glucose metabolism. Improvement of insulin sensitivity with TLR2 deficiency is present in mice fed RC, suggesting TLR2-induced insulin resistance takes place in the basal −/− mice on (e) RC and (f) HF diets. Each band represents a tissue extract from a single mouse. The intensities of the bands, quantified densitometrically relative to WT, are shown with the sample number in parentheses. *p<0.05, **p<0.01 and ***p<0.001 for Tlr2 −/− mice compared with WT mice physiological condition without the need of further HF stimulation. This raises the speculation that TLR2 ligand and the signalling it mediates are present in the basal state. Although the actual endogenous TLR2 ligands have not been identified conclusively, it has been demonstrated that TLR2 recognises a large number of lipid-containing molecules [18] , as well as endogenous proteins released from damaged tissues or injured cells [29] . It is interesting to note that the critical portion of many TLR2 ligands contains a similar fatty acid component. Removal or change of these fatty acids results in loss of TLR2 activation capability [30] , implicating an important role of these fatty acids in ligand recognition and receptor activation. Particularly, palmitic and stearic acids are known to be major fatty acids acylated in the lipoprotein or lipopeptide to activate TLR2 [31, 32] . NEFA possess the capacity to induce stress/inflammatory signals not only in immune cells but also other cell types and tissues [13, 14, 33] . This phenomenon is of particular importance in conditions of nutrient excess such as obesity and diabetes or after ingestion of a fatty meal.
Inflammation-induced activation of protein kinases, such as IKK, JNK and ERK, has been shown to inhibit tyrosine phosphorylation of IRS1 [7] [8] [9] and suppress insulin action and its downstream signalling. Serine phosphorylation of IRS1 is a general mechanism to interrupt IRS1 function and insulin-signal transduction [34, 35] . For example, phosphorylation of IRS1 at Ser307 reduces IRS1 coupling to activated insulin receptors [8] and enhances IRS1 degradation [36] . Phosphorylation of IRS1 at Ser612 decreased PI3K docking to IRS1 [37] . IRS1 Ser307 can be phosphorylated by IKK and JNK [7, 8] , whereas IRS1 Ser612 can be phosphorylated by ERK [9] . Our results showing enhanced insulin-stimulated Akt Ser473 phosphorylation and IRS1 tyrosine phosphorylation specifically in the liver of Tlr2 −/− mice provide a biochemical correlate for increased hepatic insulin sensitivity. In the search for protein kinases involved in insulin signalling that are induced by inflammatory mediators, we did not detect alterations in the activation of JNK and IKK in the livers of Tlr2 −/− mice. ERK activation was dramatically reduced in the livers of Tlr2 −/− mice, providing a possible link between TLR2 and hepatic inflammation. However, further investigation of the hypothesised phosphorylation target on IRS1 did not reveal any change in phosphorylation of Ser307 and Ser612. These results suggest that the hypothesised phosphorylation target on IRS1 mediated through TLR2 is not Ser307 or Ser612. Nevertheless, our results implicate ERK as a downstream intracellular mediator of the TLR2-induced inflammatory response influencing the insulin signal pathway through IRS1 modification. Our observation of improved insulin sensitivity in the absence of TLR2 supports and elaborates previous findings. For example, palmitate induced IL-6 production and inflammatory signalling, leading to inhibition of insulin-activated signal transduction through TLR2 in myotubes [21] . In addition, inhibition of TLR2 expression by TLR2 antisense oligonucleotide improves insulin sensitivity and signalling in muscle and WAT from mice fed the HF diet [38] . However, tissue specificity and transient treatment of antisense oligonucleotide limit the interpretation of long-term effect of TLR2 on complex physiological homeostasis. Although mice lacking TLR2 have recently been found to be protected from dietinduced adiposity and systemic insulin resistance [39], mechanistic insight and tissue specificity for the improvement of insulin sensitivity with TLR2 deficiency have been lacking. Collectively, these findings implicate TLR2 as a key mediator of inflammation, causing insulin resistance under conditions of nutrient excess in many key insulin-responsive tissues.
Despite the apparent upregulation of inflammatory cytokines in WAT of ob/ob mice, the induction of inflammatory cytokines and TLR2 was also present in the livers of ob/ob mice in our study. These findings suggest that the nutrient-induced inflammatory response and insulin resistance takes place in both WAT and liver. In support of this hypothesis, TLR2-deficiency-associated decreases in inflammatory cytokine expression and signalling and enhancement of insulin signalling were conspicuous in the liver. In contrast, the induction of inflammatory cytokines was not evident in the muscle of ob/ob mice. Consistent with this, the gene expression and signalling molecules related to inflammation and insulin resistance in muscle appeared unchanged in Tlr2 −/− mice. Thus, the modification of peripheral insulin sensitivity through TLR2-induced inflammatory cytokine expression and signalling is likely to be mediated primarily in the liver. Recently, the role of TLR4 in the cross-talk between nutrient-induced inflammation and insulin resistance has been investigated [40] [41] [42] [43] , and the hypothesised location for TLR4 action mediating the impairment of insulin sensitivity is predominantly in WAT. Different TLR production profiles affect the responsiveness of particular cell types and tissues to the ligand stimulation. In addition, different TLR ligands may induce activation of different downstream signalling pathways, leading to a diverse array of target gene expression and cellular responses through distinct TLRs. Given the differences in ligand preference, signalling pathways and tissue distribution between TLR2 and TLR4, it is reasonable to speculate that TLR2 and TLR4 may receive different ligand stimulation from nutrient factors and transduce inflammatory signals. Furthermore, there was no compensatory alteration in the gene expression of Tlr4 in WAT, liver and muscle (data not shown). Our results unequivocally provide TLR2 as another TLR family receptor involved in the interface of inflammatory response and metabolic disturbance.
In conclusion, our results demonstrated that TLR2 contributes to upregulation of inflammatory cytokine expression and signalling and interference of insulin action specifically in the liver. Although the detailed mechanism by which factors activate TLR2 or interact with its associated factors is not known, the results presented here represent a new paradigm that endogenous molecule(s) can utilise the innate immune receptor TLR2 to trigger the local inflammation-related signalling in the liver and subsequently affect systemic metabolism. Our findings provide a rationale for the development of the hepatic inflammatory response and insulin resistance in response to nutrient factors. 
